CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Cholecalciferol

胆骨化醇 杂质对照品Cholecalciferol Impurities

EP35 个杂质条目35 impurity entries

本页汇总 胆骨化醇 的 35 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 35 impurity reference standards of Cholecalciferol with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 胆骨化醇(Cholecalciferol)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDegradation studies of cholecalciferol (vitamin D3) using HPLC-DAD, UHPLC-MS/MS and chemical derivatization
    Food chemistry · 2017 · Mahmoodani F et al.  ·  PMID 27765240  ·  DOI
  2. 杂质研究Impurity studiesThe effect of various cholecalciferol-related substances on the biosynthesis of the cholecalciferol-dependent calcium-binding protein in the small intestine of the rachitic chick and its relation to rickets
    Nutrition and metabolism · 1980 · Jones LT et al.  ·  PMID 6255383  ·  DOI
  3. 杂质研究Impurity studiesStability of solid drugs: degradation of ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3) at high humidities and elevated temperatures
    Journal of pharmaceutical sciences · 1980 · Grady LT, Thakker KD  ·  PMID 6251199  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisEnzymatic synthesis of cholecalciferol glycosides using β-glucosidase from sweet almond
    Journal of food science and technology · 2010 · Manohar B, Divakar S  ·  PMID 23572673  ·  DOI
  • 合成方法SynthesisSynthesis of (24S)- and (24R)-1 alpha-hydroxy-[24-3H]-cholecalciferol
    Journal of steroid biochemistry · 1979 · Bannai K et al.  ·  PMID 449317  ·  DOI

胆骨化醇 —— 原料药与杂质对照品Cholecalciferol — drug substance & impurities

共 36 个条目(含原料药本体)36 items incl. the drug substance
Cholecalciferol structure
EP原料药 APIAPI
胆骨化醇Cholecalciferol
Cholecalciferol
CAS No.67-97-0
Chemical FormulaC27H44O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 1 (Cholecalciferol EP Impurity A) structure
EPA
胆骨化醇杂质1 (胆骨化醇EP杂质A)Cholecalciferol Impurity 1 (Cholecalciferol EP Impurity A)
Cholecalciferol Impurity 1 (Cholecalciferol EP Impurity A)
CAS No.22350-41-0
Chemical FormulaC27H44O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 2 (Cholecalciferol EP Impurity B) structure
EPB
胆骨化醇杂质2 (胆骨化醇EP杂质B)Cholecalciferol Impurity 2 (Cholecalciferol EP Impurity B)
Cholecalciferol Impurity 2 (Cholecalciferol EP Impurity B)
CAS No.434-16-2
Chemical FormulaC27H44O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 3 (Cholecalciferol EP Impurity C) structure
EPC
胆骨化醇杂质3 (胆骨化醇EP杂质C)Cholecalciferol Impurity 3 (Cholecalciferol EP Impurity C)
Cholecalciferol Impurity 3 (Cholecalciferol EP Impurity C)
CAS No.5226-01-7
Chemical FormulaC27H44O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 4 (Cholecalciferol EP Impurity D) structure
EPD
胆骨化醇杂质4 (胆骨化醇EP杂质D)Cholecalciferol Impurity 4 (Cholecalciferol EP Impurity D)
Cholecalciferol Impurity 4 (Cholecalciferol EP Impurity D)
CAS No.22350-43-2
Chemical FormulaC27H44O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 5 (Cholecalciferol EP Impurity E) structure
EPE
胆骨化醇杂质5 (胆骨化醇EP杂质E)Cholecalciferol Impurity 5 (Cholecalciferol EP Impurity E)
Cholecalciferol Impurity 5 (Cholecalciferol EP Impurity E)
CAS No.17592-07-3
Chemical FormulaC27H44O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 7 (Cholecalciferol EP Impurity F) structure
EPF
胆骨化醇杂质7 (胆骨化醇EP杂质F)Cholecalciferol Impurity 7 (Cholecalciferol EP Impurity F)
Cholecalciferol Impurity 7 (Cholecalciferol EP Impurity F)
CAS No.31316-20-8
Chemical FormulaC31H50O2
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 13 (Previtamin D3) structure
13
胆骨化醇杂质13 (前胆骨化醇)Cholecalciferol Impurity 13 (Previtamin D3)
Cholecalciferol Impurity 13 (Previtamin D3)
CAS No.1173-13-3
Chemical FormulaC27H44O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 14 structure
14
胆骨化醇杂质14Cholecalciferol Impurity 14
Cholecalciferol Impurity 14
CAS No.927822-16-0
Chemical FormulaC35H58O2
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 15 structure
15
胆骨化醇杂质15Cholecalciferol Impurity 15
Cholecalciferol Impurity 15
CAS No.158180-04-2
Chemical FormulaC37H62O2
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 16 structure
16
胆骨化醇杂质16Cholecalciferol Impurity 16
Cholecalciferol Impurity 16
CAS No.927822-17-1
Chemical FormulaC35H58O2
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 17 structure
17
胆骨化醇杂质17Cholecalciferol Impurity 17
Cholecalciferol Impurity 17
CAS No.927822-18-2
Chemical FormulaC37H62O2
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 19 (7,8-Epoxy-vitamin D3) structure
19
胆骨化醇杂质19 (7,8-环氧胆骨化醇)Cholecalciferol Impurity 19 (7,8-Epoxy-vitamin D3)
Cholecalciferol Impurity 19 (7,8-Epoxy-vitamin D3)
CAS No.89231-90-3
Chemical FormulaC27H44O2
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 20 structure
20
胆骨化醇杂质20Cholecalciferol Impurity 20
Cholecalciferol Impurity 20
CAS No.193278-59-0
Chemical FormulaC40H65N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 21 structure
21
胆骨化醇杂质21Cholecalciferol Impurity 21
Cholecalciferol Impurity 21
CAS No.156965-15-0
Chemical FormulaC32H48O5
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 22 structure
22
胆骨化醇杂质22Cholecalciferol Impurity 22
Cholecalciferol Impurity 22
CAS No.71415-74-2
Chemical FormulaC24H36O3
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 23 structure
23
胆骨化醇杂质23Cholecalciferol Impurity 23
Cholecalciferol Impurity 23
CAS No.69556-15-6
Chemical FormulaC27H44O2
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 24 structure
24
胆骨化醇杂质24Cholecalciferol Impurity 24
Cholecalciferol Impurity 24
CAS No.63819-60-3
Chemical FormulaC27H42O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 25 structure
25
胆骨化醇杂质25Cholecalciferol Impurity 25
Cholecalciferol Impurity 25
CAS No.56720-87-7
Chemical FormulaC27H44O2
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 26 structure
26
胆骨化醇杂质26Cholecalciferol Impurity 26
Cholecalciferol Impurity 26
CAS No.63819-58-9
Chemical FormulaC27H43FO
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 27 structure
27
胆骨化醇杂质27Cholecalciferol Impurity 27
Cholecalciferol Impurity 27
CAS No.36149-00-5
Chemical FormulaC27H44O2
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 28 structure
28
胆骨化醇杂质28Cholecalciferol Impurity 28
Cholecalciferol Impurity 28
CAS No.75227-71-3
Chemical FormulaC34H48O2
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 29 structure
29
胆骨化醇杂质29Cholecalciferol Impurity 29
Cholecalciferol Impurity 29
CAS No.299411-18-0
Chemical FormulaC30H50O5
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 30 structure
30
胆骨化醇杂质30Cholecalciferol Impurity 30
Cholecalciferol Impurity 30
CAS No.794516-18-0
Chemical FormulaC30H50O5
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 31 structure
31
胆骨化醇杂质31Cholecalciferol Impurity 31
Cholecalciferol Impurity 31
CAS No.99518-38-4
Chemical FormulaC22H32O3
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 33 structure
33
胆骨化醇杂质33Cholecalciferol Impurity 33
Cholecalciferol Impurity 33
CAS No.566-77-8
Chemical FormulaC22H34O3
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 37 structure
37
胆骨化醇杂质37Cholecalciferol Impurity 37
Cholecalciferol Impurity 37
CAS No.8024-19-9
Chemical FormulaC27H44O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 46 structure
46
胆骨化醇杂质46Cholecalciferol Impurity 46
Cholecalciferol Impurity 46
CAS No.57651-84-0
Chemical FormulaC27H44O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 49 structure
49
胆骨化醇杂质49Cholecalciferol Impurity 49
Cholecalciferol Impurity 49
CAS No.216161-85-2
Chemical FormulaC28H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 50 structure
50
胆骨化醇杂质50Cholecalciferol Impurity 50
Cholecalciferol Impurity 50
CAS No.1612177-56-6
Chemical FormulaC32H48O5
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 51 structure
51
胆骨化醇杂质51Cholecalciferol Impurity 51
Cholecalciferol Impurity 51
CAS No.1183-41-1
Chemical FormulaC34H46N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 52 structure
52
胆骨化醇杂质52Cholecalciferol Impurity 52
Cholecalciferol Impurity 52
CAS No.57651-82-8
Chemical FormulaC27H44O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 53 structure
53
胆骨化醇杂质53Cholecalciferol Impurity 53
Cholecalciferol Impurity 53
CAS No.174176-73-9
Chemical FormulaC27H46O3
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 56 structure
56
胆骨化醇杂质56Cholecalciferol Impurity 56
Cholecalciferol Impurity 56
CAS No.89231-92-5
Chemical FormulaC27H44O2
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 57 structure
57
胆骨化醇杂质57Cholecalciferol Impurity 57
Cholecalciferol Impurity 57
CAS No.125521-02-0
Chemical FormulaC27H42O
Purity>95%询价On request
10mg25mg50mg100mg
Cholecalciferol Impurity 62 structure
62
胆骨化醇杂质62Cholecalciferol Impurity 62
Cholecalciferol Impurity 62
CAS No.22481-38-5
Chemical FormulaC27H46O
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

胆骨化醇 —— 研究文献与合成路线Cholecalciferol — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 胆骨化醇 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Cholecalciferol. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability of solid drugs: degradation of ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3) at high humidities and elevated temperatures
    Grady LT, Thakker KD · Journal of pharmaceutical sciences · 1980 · 被引 34cited 34
  2. Degradation studies of cholecalciferol (vitamin D3) using HPLC-DAD, UHPLC-MS/MS and chemical derivatization
    Mahmoodani F, Perera CO, Fedrizzi B, et al. · Food chemistry · 2017 · 被引 45cited 45
  3. Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol
    Alshayeb H, Showkat A, Wall BM, et al. · The Journal of clinical endocrinology and metabolism · 2014 · 被引 18cited 18
  4. Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites
    Hollis BW · Journal of steroid biochemistry · 1984 · 被引 92cited 92
  5. Determination of potential content of vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol) in gelatin-coated beadlets, oil-based mixtures, and multivitamin tablet and capsule formulations
    Walker GA, Carpenter BE, Tuescher DL · Journal of pharmaceutical sciences · 1980 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. PROCESS AND INTERMEDIATES TO PREPARE THE SULPHONYL DERIVATIVES OF CHOLECALCIFEROL
    CHODYNSKI MICHAL, KRUPA MALGORZATA, FITAK HANNA, WINIARSKI JERZY, et al. · 公开号 WO2005110979WO2005110979 · 2005
  2. PROCESS AND INTERMEDIATES TO PREPARE THE SULPHONYL DERIVATIVES OF CHOLECALCIFEROL
    CHODYNSKI MICHAL, KRUPA MALGORZATA, FITAK HANNA, WINIARSKI JERZY, et al. · 公开号 EP1756048EP1756048 · 2007
  3. Pharmaceutical preparation containing alendronate sodium and cholecalciferol-cholesterol
    YUAN GAO, XUQIONG WU, BINHUA CHEN, ZHENGMING ZHU, et al. · 公开号 CN101444521CN101444521 · 2009
  4. SYNTHESIS OF 1Alpha-FLUORO-25-HYDROXY-16-23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL
    USKOKOVIC MILAN R, MARCZAK STANISLAW, LOO RALF, SLUIS MARCEL VAN DER, et al. · 公开号 KR20080050420KR20080050420 · 2008
  5. SYNTHESIS OF 1A-FLUORO-25-HYDROXY-16-23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL
    MAEHR HUBERT, USKOKOVIC MILAN R · 公开号 CA2676512CA2676512 · 2008

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

胆骨化醇 杂质谱研究要点Cholecalciferol — impurity profiling notes

下面这些是拿到 胆骨化醇 的 36 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 36 impurity entries for Cholecalciferol, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances